Needham & Company Maintains a 'Hold' on Teva Pharma (TEVA); European Generics Are Bottoming & Downside Risks Shrink

Go back to Needham & Company Maintains a 'Hold' on Teva Pharma (TEVA); European Generics Are Bottoming & Downside Risks Shrink